TAMPA – Morphogenesis Inc., a global leader in development of the cancer immunotherapy, announces that in keeping with its tradition of support for its home community and to expand its capabilities in research and development, the firm has joined the Tampa Innovation Alliance.
“The Tampa Innovation Alliance is charged with creating a vibrant live, work, play, study and stay environment in the area of the University of South Florida,” said Mark Sharpe, Executive Director of the Tampa Innovation Alliance. “Since our launch in November of 2014, nearly 100 businesses and other organizations have joined the alliance, and we are proud and delighted to have such a prestigious cancer R&D firm as Morphogenesis join our ranks.”
The University of South Florida, Busch Gardens, Moffitt Cancer Center and the University Mall comprise the executive leadership of the alliance, which is in the process of securing funding for a master planning process that will lead to redevelopment of the university area.
Patricia Lawman, Ph.D., Co-founder and CEO of Morphogenesis, said the firm has close historical ties to USF and is focused on strengthening those ties through membership in the Tampa Innovation Alliance.
“We are on the verge of some major new developments and announcements for our primary cancer vaccine, ImmuneFx™,” said Dr. Lawman. “The future looks very bright, and we look forward to becoming a key player in the significant changes planned for the vibrant and promising area served by the alliance.”
Founded by Drs. Michael and Patricia Lawman, along with a team of scientists, Morphogenesis began operations at the University of Florida’s Sid Martin Biotechnology Development Institute in Alachua more than two decades ago. Past professional associations include work at the University of Florida, the Walt Disney Memorial Cancer Institute, the University of Tennessee, Auburn University, St. Joseph’s Children’s Hospital, the University of Central Florida and the University of South Florida.
Morphogenesis is a privately-held biotechnology company structured to serve the rapidly growing cell therapy, biologics and tissue engineering markets. Morphogenesis has developed a multi-indication cancer therapy which educates the immune system to attack tumor cells throughout the body without damaging other cells or systems. Its subsidiary, Veterinary Oncology Services Inc., assists veterinary physicians in providing this non-toxic, personalized treatment for many types of cancers in cats, dogs and horses. For more information about the Lawmans and Morphogenesis, please visit www.morphogenesis-inc.com. For more information about Veterinary Oncology Services, please visit www.veterinaryoncologyservices.com.
The Tampa Innovation Alliance is a multi-jurisdictional district anchored by globally-recognized institutions that drive economic activity in the area, engaging tens of thousands of students and educators, healthcare workers and patients, and four million tourists annually. Our anchor institutions include:
• University of South Florida
• Busch Gardens
• Moffitt Cancer Center
• Florida Hospital
• RD Management (University Square Mall)
Under new leadership and with institutional support, the alliance is poised to engage business and community as we lead revitalization and renaissance – building an engaged community recognized as an innovation destination through an inclusive effort drawing from the creative minds of our community.
The Tampa Innovation Alliance comprises 25,000 acres in the northern part of Tampa: bounded by Busch Boulevard on the south, Bearss Avenue on the north, and interstates 75 and 275 on the east and west. It includes parts of Tampa, Temple Terrace and unincorporated Hillsborough County.
Our mission is to build a place that people want to live, work and play. Our vision is to transform this transient area into a destination, rather than just a thoroughfare to the university, entertainment venues or hospitals. While our cross-sector anchor institutions provide economic and social structure, we recognize that the community’s essence and identity are defined by the people who live here.

See more at: http://www.tampabaynewswire.com/2015/07/12/cancer-vaccine-development-firm-morphogenesis-joins-tampa-innovation-alliance-36605#sthash.eUcfwPKy.dpuf